Home › Funds › Elliott Investment Management › CRMD
Elliott Investment Management position in CRMD
CORMEDIX INC · Health Care
Latest position (Q1 2025)2.44M sh
Reported value held$15.06M
Portfolio Weight0.10%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.55M | $7.21M | New |
| Q4 2021 | 1.55M | $7.05M | Hold |
| Q1 2022 | 1.55M | $8.50M | Hold |
| Q2 2022 | 1.55M | $6.23M | Hold |
| Q3 2022 | 1.55M | $4.39M | Hold |
| Q4 2022 | 1.55M | $6.54M | Hold |
| Q1 2023 | 1.55M | $6.42M | Hold |
| Q2 2023 | 1.55M | $6.15M | Hold |
| Q3 2023 | 1.55M | $5.74M | Hold |
| Q4 2023 | 1.55M | $5.83M | Hold |
| Q1 2024 | 1.55M | $6.57M | Hold |
| Q2 2024 | 1.55M | $6.71M | Hold |
| Q3 2024 | 1.55M | $12.53M | Hold |
| Q4 2024 | 2.87M | $23.25M | Add |
| Q1 2025 | 2.44M | $15.06M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CRMD
- Vanguard Group 4.50M sh · $52.32M · Q4 2025
- BlackRock Inc 6.32M sh · $49.64M · Q2 2026
- Royce & Associates 2.18M sh · $17.08M · Q2 2026
- Geode Capital Management 1.95M sh · $15.29M · Q2 2026
- UBS Group AG 1.88M sh · $14.74M · Q2 2026
- Marshall Wace 779.53K sh · $6.12M · Q2 2026
- Northern Trust Corp 756.43K sh · $5.94M · Q2 2026
- Charles Schwab Investment Management 618.17K sh · $4.85M · Q2 2026
- Goldman Sachs Group 466.39K sh · $3.66M · Q2 2026
- Morgan Stanley 423.34K sh · $3.32M · Q2 2026
- BNY Mellon 395.91K sh · $3.11M · Q2 2026
- Citadel Advisors 358.11K sh · $2.81M · Q2 2026